Gastritis
📧 Sign up to get email alerts when something new happens for Gastritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing high-dose esomeprazole and amoxicillin dual therapy to bismuth-containing quadruple therapy for Helicobacter pylori-…
-
FDA approval · 2022-12-23FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for the combination drug chlordiazepoxide hydrochloride and clidinium bromide (brand name Librax) ma…
-
FDA approval · 2022-07-28FDA Approved: CURIST ACID RELIEF — Supplemental Application (Little Pharma, Inc.)
FDA granted a supplemental approval for Curist Acid Relief containing famotidine 20 mg from Little Pharma, Inc., updating the ANDA with the …
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis [Phase 3]
Phase 3 trial evaluating HIP2101 for gastritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: i-Scan for the Detection of Helicobacter Pylori [NA]
Clinical trial evaluating i-Scan for detecting Helicobacter pylori in gastritis patients has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-02-18FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for PEPCID AC MAXIMUM STRENGTH (famotidine) from Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing probiotics plus triple therapy against bismuth-containing quadruple therapy for Helicobacter pylori eradication in g…
-
FDA approval · 2022-01-07FDA Approved: FAMOTIDINE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for famotidine, establishing a new generic entry for the acid-reducing medication…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis [Phase 3]
Phase 3 trial evaluating DWP14012 for acute or chronic gastritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of CKD-495 for gastritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. [Phase 4]
Clinical trial update for Stillen Tab evaluating efficacy and non-inferiority in a Phase 4 study for acute and chronic gastritis.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Helicobacter Pylori Eradication With a New Sequential Treatment [Phase 3]
Phase 3 trial update on a new sequential treatment for Helicobacter pylori eradication completed.
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis [Phase 3]
Phase 3 trial assessing efficacy and safety of MCT-SR in patients with acute or chronic gastritis has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-203 [Phase 3]
Phase 3 trial evaluating AD-203 for acute and chronic gastritis has completed.
-
FDA approval · 2020-06-23FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Civica, Inc.)
The FDA approved a supplemental application for pantoprazole sodium submitted by Civica, Inc. with this action representing an approved supp…
-
FDA label_change · 2020-05-13FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)
FDA approved a supplemental application for famotidine (Carlsbad Technology, Inc.), resulting in changes to its labeling.
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for esomeprazole magnesium, a generic proton pump inhibitor.
-
FDA approval · 2020-02-21FDA Approved: CIMETIDINE 200 ACID REDUCER — Supplemental Application (Walgreen Company)
The FDA approved a supplemental application for Walgreens' CIMETIDINE 200 ACID REDUCER, indicating approval of changes to the approved gener…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets [Phase 4]
Phase 4 clinical trial evaluating eradication of Helicobacter pylori using Clostridium butyricum capsules and Bacillus coagulans tablets in …
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy [Phase 4]
A Phase 4 trial comparing berberine-amoxicillin quadruple therapy to tetracycline-furazolidone quadruple therapy for Helicobacter pylori-rel…
-
FDA approval · 2019-08-07FDA Approved: RANITIDINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for ranitidine submitted by Rising Pharma Holdings, Inc., indicating an approved change to the p…
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis [Phase 3]
Phase 3 trial of DWC20155/DWC20156 combination therapy for gastritis was terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis [Phase 3]
BEKINDA (ondansetron 24 mg bimodal release tablets) was studied in a Phase 3 trial for vomiting due to presumed acute gastroenteritis or gas…
-
CLINICAL_TRIALS research · 2019-02-19Clinical Trial Update: A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin [NA]
An ongoing multi-center clinical trial is evaluating eradication of Helicobacter pylori using clarithromycin-based triple therapy. The trial…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of CKD-495 tablet for gastritis has completed.